Buscar
BCPE Perseus Investor Ord Shs (Proposed)
KLRAAñadir a la lista de seguimiento
18.205USD
-0.345-1.86%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
2.25BCap. mercado
--P/E TTM
Más Datos de BCPE Perseus Investor Ord Shs (Proposed) Compañía
Kailera Therapeutics Inc is a United States-based company. The Company is a clinical-stage biopharmaceutical company developing a broad and advanced therapeutic pipeline that is poised to deliver differentiated treatment options for obesity and related conditions. Its pipeline consists of clinical- and preclinical-stage programs with injectable peptides, oral peptides, and an oral small molecule.
Información de BCPE Perseus Investor Ord Shs (Proposed)
Símbolo de cotizaciónKLRA
Nombre de la empresaKailera Therapeutics Inc
Fecha de salida a bolsaApr 17, 2026
Director ejecutivoRenaud (Ron)
Número de empleados- -
Tipo de seguridadOrdinary Share
Fin del año fiscal- -
Dirección180 Third Ave
CiudadWALTHAM
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal02451
Teléfono15084409475
Sitio Webhttps://www.kailera.com
Símbolo de cotizaciónKLRA
Fecha de salida a bolsaApr 17, 2026
Director ejecutivoRenaud (Ron)
Ejecutivos de BCPE Perseus Investor Ord Shs (Proposed)
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
,
,
--
--
Mr. Ron Renaud
Mr. Ron Renaud
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Paul Burgess
Mr. Paul Burgess
Chief Operating Officer, Chief Business Officer
Chief Operating Officer, Chief Business Officer
--
--
Ms. Paula Cloghessy
Ms. Paula Cloghessy
Chief People Officer
Chief People Officer
--
--
Mr. Scott M. Akamine, J.D.
Mr. Scott M. Akamine, J.D.
Chief Legal Officer, Secretary
Chief Legal Officer, Secretary
--
--
Ms. Jamie Coleman
Ms. Jamie Coleman
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Douglas W. Pagan
Mr. Douglas W. Pagan
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Scott Wasserman, M.D.
Dr. Scott Wasserman, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. John F. Milligan, Ph.D.
Dr. John F. Milligan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Franklin K. (Frank) Clyburn, Jr.
Mr. Franklin K. (Frank) Clyburn, Jr.
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
,
,
--
--
Mr. Ron Renaud
Mr. Ron Renaud
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Paul Burgess
Mr. Paul Burgess
Chief Operating Officer, Chief Business Officer
Chief Operating Officer, Chief Business Officer
--
--
Ms. Paula Cloghessy
Ms. Paula Cloghessy
Chief People Officer
Chief People Officer
--
--
Mr. Scott M. Akamine, J.D.
Mr. Scott M. Akamine, J.D.
Chief Legal Officer, Secretary
Chief Legal Officer, Secretary
--
--
Ms. Jamie Coleman
Ms. Jamie Coleman
Chief Commercial Officer
Chief Commercial Officer
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de BCPE Perseus Investor Ord Shs (Proposed)?
Los cinco principales accionistas de BCPE Perseus Investor Ord Shs (Proposed) son: ,